page

Labarai

A matsayin kasa key high-tech sha'anin da kuma m matukin jirgi sha'anin, taigui Pharmaceutical ya ko da yaushe manne wa dabarun na "revitalking da sha'anin ta hanyar kirkire-kirkire" da kuma da kansa kafa Shanghai R & D cibiyar, academician aiki da post doctoral bincike mobile tashar a kan dandamali na Shanghai da Hangzhou.

Cibiyar tana da ma'aikatan R & D fiye da 100, ciki har da masanin kimiyya 1, injiniya 1 na kasashen waje, 500 a Shanghai, ƙwararrun ƙwararrun 6, 1 wanda ya lashe lambar yabo ta abokantaka ta yammacin tafkin da kuma fiye da 30 masters.Cibiyar tana da cikakken hadin gwiwa tare da Kwalejin Kimiyya ta kasar Sin, Jami'ar Al'ada ta Gabashin kasar Sin, Jami'ar Zhejiang, Jami'ar Fudan da sauran sanannun jami'o'i na gida da cibiyoyin bincike na kimiyya, yadda ya kamata ta fahimci cudanya da hadewar bayanai, basira, fasaha da fasaha. sauran albarkatu, da kuma dagewa da ƙarfafa ƙarfin kamfani don yin gaggawar zuwa sahun gaba na kimiyya da fasaha.

Kamfanin yana da shekaru 20 gwaninta a cikin bincike na al'ada da haɓakawa da samarwa, samfurori suna rufe tsarin fara kayan aiki, tsaka-tsaki da apis.Masana'antu ya zama taigui Pharmaceutical bincike da ci gaba da kuma gyare-gyare na core kasuwanci, don samar da duniya abokan ciniki daga dukan aiwatar da bincike da kuma ci gaba da kasuwanci samar da sabis, a lokaci guda kamfanin ya tattara wani PhD, master digiri na biyu dalibi tawagar, alhakin. gudanar da aikin, bincike da haɓakawa, gyare-gyare da gudanar da aiki, don tabbatar da cewa ci gaban sabis na al'ada babban matakin, inganci da inganci.

Kamfanin ya ƙware a hankali fasahohin fermentation na halitta, canjin enzyme da haɗin sinadarai, kuma ya sami babban matsayi a cikin masana'antar.Haka kuma, tare da m samar da fasaha abũbuwan amfãni da kuma arziki masana'antu gwaninta, taigui Pharmaceutical ya yadda ya kamata inganta samar yadda ya dace da kuma samfurin ingancin, kafa dogon lokaci da kuma barga hadin gwiwa dangantaka tare da yawa manyan downstream abokan ciniki na steroidal kwayoyi a gida da kuma kasashen waje, da kuma sannu a hankali gane ci gaban. tallace-tallace har ma da aiki.

Har ila yau, kamfanin zai gudanar da ayyukan kirkire-kirkire na R&D da tsare-tsare masu tasowa.Dangane da fasahar samar da asali na asali, kamfanin zai mika zuwa matsakaici da samfurori na API na jerin shirye-shiryen steroid masu girma ta hanyar haɓaka R & D zuba jari da haɗin gwiwar waje, shimfida sabon layin samfurin, ƙarfafa mahimmanci, haɓaka gaba da inganta haɓakawa da haɓakawa ci gaban kasuwanci.


Lokacin aikawa: Juni-03-2019